Unaudited Interim Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Operating Activities
Net earnings (loss)	$ 586	$ 705
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities
Asset impairments	1	0
Depreciation, amortization and accretion	257	226
Pension and postretirement net periodic benefit cost	(37)	(85)
Pension and postretirement contributions	(53)	(83)
Deferred income taxes, net	4	(8)
(Gain) loss on disposition of businesses and assets, net	7	5
Stock-based compensation	32	26
Undistributed earnings in unconsolidated affiliates	(16)	(51)
Other, net	6	15
Operating cash provided by (used in) discontinued operations	3	5
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net	(16)	(175)
Inventories	20	7
Other assets	13	22
Trade payables - third party and affiliates	(98)	45
Other liabilities	17	142
Net cash provided by (used in) operating activities	726	796
Investing Activities
Capital expenditures on property, plant and equipment	(168)	(189)
Acquisitions, net of cash acquired	(3)	0
Proceeds from sale of businesses and assets, net	0	0
Capital expenditures related to Fairway Methanol LLC	(263)	(275)
Other, net	(27)	(13)
Net cash provided by (used in) investing activities	(461)	(477)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less	346	12
Proceeds from short-term borrowings	40	47
Repayments of short-term borrowings	(60)	(70)
Proceeds from long-term debt	0	387
Repayments of long-term debt	(18)	(19)
Purchases of treasury stock, including related fees	(420)	(201)
Stock option exercises	2	4
Series A common stock dividends	(131)	(106)
Contributions from noncontrolling interests	187	194
Other, net	(10)	(11)
Net cash provided by (used in) financing activities	(64)	237
Exchange rate effects on cash and cash equivalents	(29)	(30)
Net increase (decrease) in cash and cash equivalents	172	526
Cash and cash equivalents as of beginning of period	780	984
Cash and cash equivalents as of end of period	$ 952	$ 1,510